We are live on ! Find out more
KACL

Kairous Acquisition Corp. Limited Ordinary Shares

Delisted

KACL was delisted on the 20th of December, 2024.

13 hedge funds and large institutions have $22.3M invested in Kairous Acquisition Corp. Limited Ordinary Shares in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 7 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

54% less funds holding

Funds holding: 2813 (-15)

66% less capital invested

Capital invested by funds: $65.1M → $22.3M (-$42.8M)

79% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 19

86% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 7

Holders
13
Holders Change
-15
Holders Change %
-53.57%
% of All Funds
0.21%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
1
Reduced
7
Closed
19
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
OCAM
1
Owl Creek Asset Management
New York
$4.91M +$4.84M +475,000 New
PAMP
2
Polar Asset Management Partners
Ontario, Canada
$4.26M +$764K +75,000 +22%
GCL
3
Glazer Capital LLC
New York
$2.22M -$5.5M -539,573 -72%
AA
4
AQR Arbitrage
Connecticut
$2.18M
Hudson Bay Capital Management
5
Hudson Bay Capital Management
Connecticut
$2.14M -$2.15M -211,500 -51%
SCM
6
Shaolin Capital Management
Florida
$2.07M -$4.65M -456,158 -70%
PC
7
Periscope Capital
Ontario, Canada
$1.55M -$1.66M -162,984 -52%
RCM
8
Rivernorth Capital Management
Florida
$1.54M +$1.51M +148,636 New
PCM
9
Prelude Capital Management
New York
$1.03M +$1.02M +100,000 New
MSU
10
Mizuho Securities USA
New York
$256K +$257K +25,200 New
WAM
11
Wolverine Asset Management
Illinois
$122K -$2.7M -264,892 -96%
UBS Group
12
UBS Group
Switzerland
$18.4K -$1.84K -181 -9%
TRCT
13
Tower Research Capital (TRC)
New York
$9K -$20 -2 -0.2%
SCM
14
Saba Capital Management
New York
-$5.8M -575,000 Closed
WAM
15
Weiss Asset Management
Massachusetts
-$5.46M -541,900 Closed
Janus Henderson Group
16
Janus Henderson Group
United Kingdom
-$3.62M -359,612 Closed
D.E. Shaw & Co
17
D.E. Shaw & Co
New York
-$3.17M -315,294 Closed
KIM
18
Karpus Investment Management
New York
-$2.82M -280,675 Closed
LP
19
LMR Partners
United Kingdom
-$2.7M -267,964 Closed
MI
20
MMCAP International
Cayman Islands
-$1.92M -190,229 Closed
CCM
21
Context Capital Management
California
-$1.81M -180,000 Closed
OCM
22
Oaktree Capital Management
California
-$1.51M -150,000 Closed
CM
23
Cohanzick Management
New York
-$1.01M -100,000 Closed
RCM
24
Radcliffe Capital Management
Pennsylvania
-$1.01M -100,000 Closed
RA
25
RiverPark Advisors
New York
-$1.01M -100,000 Closed

KACL Hedge Fund Activity: Q4 2022 in Review

13 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Kairous Acquisition Corp. Limited Ordinary Shares (KACL) for Q4 2022, worth a combined $22.3M — down 66% from $65.1M a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of KACL and 4 opened new positions — a net loss of 15 holders — while 7 trimmed existing stakes and 1 added.

The largest buyer was Owl Creek Asset Management, opening a new position worth an estimated $4.84M. The largest seller was Saba Capital Management, exiting entirely with an estimated $5.8M sold.

  • 13 institutional investors held Kairous Acquisition Corp. Limited Ordinary Shares (KACL) as of Q4 2022, down from 28 in Q3 2022.
  • Funds reported $22.3M of Kairous Acquisition Corp. Limited Ordinary Shares stock for Q4 2022, down 66% quarter-over-quarter.
  • 4 funds opened new Kairous Acquisition Corp. Limited Ordinary Shares positions in Q4 2022 and 19 closed out, a net change of -15 holders.
  • The largest Kairous Acquisition Corp. Limited Ordinary Shares buyer in Q4 2022 was Owl Creek Asset Management, an estimated $4.84M added.
  • The largest Kairous Acquisition Corp. Limited Ordinary Shares seller in Q4 2022 was Saba Capital Management, an estimated $5.8M sold.

Based on aggregated 13F filings for Q4 2022.